Merck

WHCD Shooting, DOJ Ends Powell Probe, Musk Vs. Altman and More in Morning Squawk

Diagonal Banks Another $125M for ‘Clustering’ Antibody Drugs

Merck Backs Off Revolution After Failing To Agree on Price: WSJ

Merck Completes $5.3 B Purchase of Terns, Adding Oral CML Drug TERN‑701

Biopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes

Clinical Trial Failures of 2026

AbbVie, Amgen, Lilly Lead Calls for FDA To Update Post-Approval Change Rules

Iridius Raises $8.6M Seed Round to Build Compliance-by-Design AI Platform for Regulated Enterprise Workflows

Hims & Hers Expands Personalized Digital Healthcare Platform

How Merck Plans to Set a Buffer for Keytruda's Patent Cliff

FDA Lifts Partial Hold on Merck, Daiichi's Phase 3 Lung Cancer Study

S&P 500, Nasdaq Nab Best Weeks Since November: Stock Market Today

Eli Lilly Raises $9 Billion in Record Investment‑Grade Bond Offering to Finance Acquisitions

Breast Cancer Treatments Heat Up: Six Therapies Poised to Transform Patient Outcomes

Evercore ISI Says Sun Pharma Deal Talk for Organon & Co. (OGN) Lacks Confirmation, Remains Speculative

Healthtech, Biotech: Why the UK Is Emerging as an Essential Hub

Servier Signs €1bn-Plus AI Pact with Iktos

FDA Grants Priority Review to Ifinatamab Deruxtecan for Treated Small Cell Lung Cancer

FDA Sets Feb. 1 Launch Date for PreCheck Pilot To Strengthen Domestic Supply Chain

Regeneron Shares Tumble 6% After Phase 3 Melanoma Trial Misses Statistical Significance

Galactose Alters Early-Life Development and Exerts Sex-Specific Nutritional Programming Effects on Lifespan in Drosophila Melanogaster

Tuneable Peptide Biotech Parabilis Files IPO

Former Sen. Ben Sasse Shines the Spotlight on a Possible Breakthrough for Pancreatic Cancer

Eli Lilly to Acquire Kelonia Therapeutics in $7 B Cash Deal

Merck Splits Operations to Separate Oncology From Non-Cancer Drugs

European Stocks Rally 0.8% on Mining, Energy and Tech Gains Amid Iran Conflict

This Pill May Help Pancreatic Cancer Patients Live Longer

BBOT Shakes up Leadership as RAS Competitors Get More Visibility

Alteogen Wins PTAB Ruling, Halting Halozyme's Challenge to ALT‑B4 Manufacturing Patent

‘Almost Like a Religion’: Pfizer CEO Slams RFK Jr.’s 'Anti-Science' Vaccine Policies

Flagship CEO Calls Out Attacks on Science, Warns of China Dominance

PharmaShots Quarterly Outlook: The Forces Reshaping Biopharma in Q1 2026

LogicMonitor Defines the Autonomous IT Era with AI That Sees, Reasons, and Acts

Pfizer’s Oncology Sales Poised for Growth Ahead of Q1 Earnings

Permittivity Provides an In-Line Cell Health Early-Warning System

Overmedicalization? RFK Jr.’s Antidepressant Crackdown Raises Conflict Questions over His Fee Stake in Wisner Baum, the Tort Firm Built on Suing Drug Makers

Stock Market Today: Nasdaq Pares Losses, Powell Notes Resilient Economy; Mag 7 Earnings Loom (Live Coverage)

What’s in a Name? Moderna’s “Vaccine” Vs. “Therapy” Dilemma

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

In the Clinic for April 22, 2026

Pfizer's Oncology Portfolio Targets Growth Ahead of May 5 Earnings

Novartis Antimalarial Clears Key WHO Review to Get the Combo Drug to Babies

Toward Equitable Access to Cell and Gene Therapies: Rethinking Co-Payments

Frontier Medicines Grants Ex-China Rights of FMC-220 to LG Chem

Novo Launches Oral Obesity Pill, Lilly Targets Lofty Revenue, FDA and M&A in Focus

AbbVie’s New Immunology Standard-Bearer Skyrizi Kneels to UCB’s Bimzelx in Psoriatic Arthritis

Interna Therapeutics Collaborates with Daiichi Sankyo to Develop MNM-Based Targeted Delivery Technologies

TotalEnergies Inks 1GW Google Solar Deal

Neurocrine Nabs Rare Obesity Disorder Drug in ‘Surprising’ $2.9B Soleno Deal

IO Shuts Down Following Regulatory Roadblocks

Merck to Acquire Cidara Therapeutics to Advance Universal Flu Vaccine

MSD Completes $5.3B Acquisition of Terns Pharmaceuticals

Merck Exercises Option to License Evaxion's EVX‑B3 Infectious Disease Vaccine Candidate

Solve Therapeutics Raises $120M in Oversubscribed Funding Round

Merck to Acquire Terns Pharmaceuticals for $6.7B